Crossmark

The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer

Crossref DOI link: https://doi.org/10.1007/s00280-018-3652-2

Published Online: 2018-07-24

Published Print: 2018-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamaguchi, Kyoko

Kusaba, Hitoshi

Makiyama, Akitaka

Mitsugi, Kenji

Uchino, Keita

Tamura, Shingo

Shibata, Yoshihiro

Esaki, Taito

Ito, Mamoru

Takayoshi, Kotoe

Tsuchihashi, Kenji

Arita, Shuji

Ariyama, Hiroshi

Akashi, Koichi

Baba, Eishi https://orcid.org/0000-0001-9428-6772
License Information

Text and Data Mining valid from 2018-07-24
More Information

Article History

Received: 29 March 2018

Accepted: 18 July 2018

First Online: 24 July 2018

Compliance with ethical standards

:

: Koichi Akashi and Eishi Baba have received research grants from Yakult Honsha, Eli Lilly, Taiho Pharm, Chugai Pharm, and Nippon Kayaku. Taito Esaki received research grants from mentioned above other than Chugai Pharm. Koichi Akashi has received a speaker honorarium from Chugai Pharm. Eishi Baba has received a speaker honorarium from Chugai Pharm and Eli Lilly. Akitaka Makiyama and Taito Esaki received a speaker honorarium from Yakult Honsha, Eli Lilly, Taiho Pharm, Chugai Pharm, and Nippon Kayaku.

: Informed consent was obtained from all individual participants included in the study.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.